Limited utility of number needed to treat and the polarity index for bipolar disorder to characterize treatment response

European Neuropsychopharmacology

Volumn 23, Issue 11, 2013, Pages 1597-1599

  Alphs, Larry ^a   Berwaerts, Joris ^a   Turkoz, Ibrahim ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Bipolar disease; Limitation; Number needed to treat; Polarity index

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; MANIA; MENTAL DISEASE; NUMBERS NEEDED TO TREAT; POLARITY INDEX; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RELAPSE; RISK BENEFIT ANALYSIS; RISK REDUCTION; STATISTICAL PARAMETERS; TREATMENT RESPONSE;

BIPOLAR DISEASE; LIMITATION; NUMBER NEEDED TO TREAT; POLARITY INDEX;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CONFIDENCE INTERVALS; EVIDENCE-BASED MEDICINE; HUMANS; NUMBERS NEEDED TO TREAT; RECURRENCE; REPRODUCIBILITY OF RESULTS; SYMPTOM ASSESSMENT;

EID: 84886794151     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.12.006     Document Type: Article

References (12)

1. Bartzokis G. Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 2012, 62:2137-2153.
2. Citrome L., Katrowitz J. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks. Expert Rev. Neurother. 2008, 8(7):1079-1091.
3. Citrome L. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgrad Med 2010, 122(4):39-48.
4. Citrome L. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?. Clin. Schizo. Rel. Psych. 2012, 75-85.
5. Hutton J.L. Number needed to treat: properties and problems. J. R. Stat. Soc. A 2000, 163(Part 3):403-419.
6. Lesaffre E., Pledger G. A note on the number needed to treat. Control Clin. Trials 1999, 20(5):439-447.
7. Popovic D., Reinares M., Amann B., Salamero M., Vieta E. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder. Psychopharmacology (Berl). 2011, 213(4):657-667. Epub 2010 October 31.
8. Popovic D., Reinares M., Goikolea J.M., Bonnin C.M., Gonzalez-Pinto A., Vieta E. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur. Neuropsychopharmacol. 2012, 22(5):339-346.
9. Smeeth L., Haines A., Ebrahim S. Numbers needed to treat derived from meta-analyses-sometimes informative, usually misleading. Br. Med. J. 1999, 318(7197):1548-1551.
10. Stang A., Poole C., Bender R. Common problems related to the use of number needed to treat. J. Clin. Epidemiol. 2010, 63:820-825.
11. Suissa D., Brassard P., Smiechowski B., Suissa S. Number needed to treat is incorrect without proper time-related considerations. J. Clin. Epidemiol. 2012, 65(1):42-46. Epub 2011 August 4.
12. Thabane L. A closer look at the distribution of number needed to treat (NNT): a Bayesian approach. Biostatistics 2003, 4(3):365-370.